Hasan Jafri - Net Worth and Insider Trading
Hasan Jafri Net Worth
The estimated net worth of Hasan Jafri is at least $310 dollars as of 2024-05-23. Hasan Jafri is the Chief Medical Officer of Aridis Pharmaceuticals Inc and owns about 5,100 shares of Aridis Pharmaceuticals Inc (ARDS) stock worth over $310. Details can be seen in Hasan Jafri's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hasan Jafri has not made any transactions after 2021-09-07 and currently still holds the listed stock(s).
Transaction Summary of Hasan Jafri
Hasan Jafri Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hasan Jafri owns 1 companies in total, including Aridis Pharmaceuticals Inc (ARDS) .
Click here to see the complete history of Hasan Jafri’s form 4 insider trades.
Insider Ownership Summary of Hasan Jafri
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARDS | Aridis Pharmaceuticals Inc | 2021-09-07 | Chief Medical Officer |
Hasan Jafri Latest Holdings Summary
Hasan Jafri currently owns a total of 1 stock. Hasan Jafri owns 5,100 shares of Aridis Pharmaceuticals Inc (ARDS) as of September 7, 2021, with a value of $310.
Latest Holdings of Hasan Jafri
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARDS | Aridis Pharmaceuticals Inc | 2021-09-07 | 5,100 | 0.06 | 310 |
Holding Weightings of Hasan Jafri
Hasan Jafri Form 4 Trading Tracker
According to the SEC Form 4 filings, Hasan Jafri has made a total of 1 transactions in Aridis Pharmaceuticals Inc (ARDS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aridis Pharmaceuticals Inc is the acquisition of 5,100 shares on September 7, 2021, which cost Hasan Jafri around $21,165.
Insider Trading History of Hasan Jafri
- 1
Hasan Jafri Trading Performance
GuruFocus tracks the stock performance after each of Hasan Jafri's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hasan Jafri is -40.39%. GuruFocus also compares Hasan Jafri's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hasan Jafri within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hasan Jafri's insider trading performs compared to the benchmark.
Performance of Hasan Jafri
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.26 | | | | | |
| Relative Return to S&P 500(%) | -13.6 | | | | | |
Hasan Jafri Ownership Network
Hasan Jafri Owned Company Details
What does Aridis Pharmaceuticals Inc do?
Who are the key executives at Aridis Pharmaceuticals Inc?
Hasan Jafri is the Chief Medical Officer of Aridis Pharmaceuticals Inc. Other key executives at Aridis Pharmaceuticals Inc include 10 percent owner Fibrosis Foundation Cystic , director & 10 percent owner & CEO & CSO & Director Vu Truong , and director & 10 percent owner Eric Patzer .
Aridis Pharmaceuticals Inc (ARDS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aridis Pharmaceuticals Inc (ARDS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aridis Pharmaceuticals Inc (ARDS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aridis Pharmaceuticals Inc (ARDS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aridis Pharmaceuticals Inc Insider Transactions
Hasan Jafri Mailing Address
Above is the net worth, insider trading, and ownership report for Hasan Jafri. You might contact Hasan Jafri via mailing address: 5941 Optical Court, San Jose Ca 95138.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
